Press release
Inherited Retinal Disease Market Intelligence Report Covers Trends, Segments And Regional Growth
Inherited Retinal Disease Market
Projected Growth Trajectory of the Inherited Retinal Disease Market
The inherited retinal disease market is forecasted to experience a substantial rise, reaching a valuation of $18.62 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 8.2%. Factors powering this growth include innovations in gene therapy platforms, an increase in approvals for novel retinal treatments, broader access to genetic screening initiatives, the rise of precision medicine programs, and heightened investments in rare ophthalmic disease research pipelines. Prominent trends expected to influence the market encompass the growing use of genetic testing for early diagnosis, greater emphasis on gene and cell-based therapies, expansion of personalized care strategies, a surge in clinical trials targeting rare retinal disorders, and enhanced patient access to advanced retinal imaging technologies.
The inherited retinal disease market size has grown strongly in recent years. It will grow from $12.54 billion in 2025 to $13.6 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to identification of disease-causing retinal genes, advancements in retinal imaging technologies, increased awareness of inherited eye disorders, growth of specialized ophthalmology clinics, public and private funding for rare disease research.
Download a free sample of the inherited retinal disease market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20850&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Key Companies Steering the Inherited Retinal Disease Industry
Several notable organizations lead the inherited retinal disease market, including Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, and Endogena Therapeutics.
In a strategic move to enhance its gene therapy portfolio, Ocuphire Pharma, Inc., a US-based biopharmaceutical firm, acquired Opus Genetics Inc. in October 2024. This acquisition aims to accelerate the development of novel treatments for inherited retinal diseases by incorporating Opus Genetics' advanced gene therapies focused on rare retinal conditions. Opus Genetics Inc. is recognized as a clinical-stage gene therapy company based in the United States with a specialization in inherited retinal diseases.
Emerging Trends Creating New Opportunities in the Inherited Retinal Disease Space
Innovations in therapy development are at the forefront, with many companies dedicating efforts to mutation-agnostic gene therapies. This approach targets broader genetic pathways rather than specific mutations, allowing treatments to address a wider spectrum of genetic variations associated with inherited retinal diseases.
As an illustration, in March 2024, Nanoscope Therapeutics Inc., a biotechnology firm from the US, announced positive clinical trial outcomes for its lead candidate, MCO-010. This therapy demonstrated statistically significant improvements in vision for patients suffering from advanced retinitis pigmentosa with permanent and severe vision loss. Importantly, MCO-010 met all primary and key secondary trial endpoints without serious adverse events, underscoring its therapeutic potential.
View the full inherited retinal disease market report:
https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Market Segmentation Highlighting the Largest Share in the Inherited Retinal Disease Market
The inherited retinal disease market is categorized into several segments for better understanding:
1) By Type: Diagnosis and Therapy
2) By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rod Dystrophy, Leber Congenital Amaurosis, and Other Diseases
3) By Distribution Channel: Retail Sales and Direct Tender
4) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centres, Home Healthcare, and Other End Users
Further detailed subsegments include:
1) Diagnosis: Genetic Testing, Retinal Imaging, Electrophysiological Testing (Electroretinography), Visual Field Testing, and Fundus Autofluorescence Imaging
2) Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy, and Photoreceptor Rescue Therapy
This detailed segmentation underscores the diverse approaches and channels through which inherited retinal diseases are diagnosed and treated, reflecting the market's complexity and potential for future growth.
New analytical features added to our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inherited Retinal Disease Market Intelligence Report Covers Trends, Segments And Regional Growth here
News-ID: 4608808 • Views: …
More Releases from The Business Research Company
Iodine Market Research Reveals Path To $4.37 Billion By 2030
The iodine industry is on track for significant expansion in the upcoming years, driven by a variety of factors across healthcare, manufacturing, and sustainability sectors. As demand increases for this versatile element in diverse applications, the market is positioning itself for robust growth through innovative technologies and strategic partnerships.
Projected Market Value and Growth Expectations for the Iodine Industry
The iodine market is forecasted to reach a value of $4.37…
Invasive Aspergillosis Therapeutics Market Outlook Signals Expansion To $1.41 Bi …
The invasive aspergillosis therapeutics market is on a steady growth path, driven by advancements in antifungal treatments and heightened awareness of fungal infections. This report delves into the current market size, key players, prevailing trends, and segment-wise forecast, offering a comprehensive snapshot of this critical healthcare sector.
Anticipated Market Size of the Invasive Aspergillosis Therapeutics Industry by 2030
The invasive aspergillosis therapeutics sector is projected to expand steadily, reaching a…
Intravenous (IV) Ibuprofen Market Report 2026 Market Outlook Supported By A Fore …
The intravenous (IV) ibuprofen market is positioned for significant expansion in the coming years as healthcare providers increasingly seek effective, opioid-sparing pain management solutions. With new treatment protocols and growing demand across various patient groups, this sector is set to experience substantial growth and innovation. Here is an overview of the market's size, key players, emerging trends, and segmentation.
Rapid Expansion Predicted for the Intravenous Ibuprofen Market by 2030
The…
Intraoral/IOL Scanners Market Insights Highlight Segment Expansion And Market Le …
The intraoral/IOL scanners market is rapidly evolving, propelled by technological advancements and shifting dental care practices. As digital dentistry continues to transform patient treatment, the demand for efficient, accurate, and patient-friendly scanning devices is on the rise. Let's explore the market's forecasted size, key players, emerging trends, and the segments shaping this expanding industry.
Expected Market Size and Growth Trajectory for Intraoral/IOL Scanners
The intraoral/IOL scanners market is projected to…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
